CRM: Targeting Integrin-alpha Protein Reduces Cancer Aggressiveness
Scientists from the Madrid Institute of Oncology have found that targeting a specific protein, integrin-alpha, suppresses the ability of cancer cells to migrate. The results of the study were published in the journal Cell Reports Medicine.
According to Professor Guillermo , lead author of the study, inhibiting integrin-alpha activity significantly reduces the ability of tumor cells to migrate. In laboratory experiments, scientists were able to reduce metastatic activity by 70%.
US President Donald Trump once again mentioned Russian forward and Washington Capitals captain Alexander Ovechkin during his speech, RIA Novosti reports.
Trump spoke about Ovechkin at a rally held after the bc data china at Capital One Arena, the home of the Washington Capitals.
"I'd like to say thank you. Just look at this arena and the people in it. There's not a single seat left. Thank you to everyone in this arena, you guys are fantastic. The hockey team is great, too. Ovechkin is very good, right? He does a great job. Thank you to the arena, it's fantastic!" Trump said.
Trump previously called Ovechkin a "great player" during a rally in Washington.
Scientists have also developed an experimental drug that blocks the work of integrin-alpha. Preclinical tests on laboratory animals showed encouraging results: the drug slowed tumor growth without causing significant side effects. According to scientists, these properties open up new prospects for its further use in oncology.